Study Shows Immune-suppressed IBD Patients Have Inadequate Counseling on How To Protect Skin

Study Shows Immune-suppressed IBD Patients Have Inadequate Counseling on How To Protect Skin
Counseling on skin protection is insufficient among immune-suppressed patients with inflammatory bowel disease (IBD), according to the results of a study recently presented at the Advances in Inflammatory Bowel Disease Annual Meeting (Dec. 10-12, 2015), held in Orlando. “Potential adverse effects of immune-suppressing medications require patient education and counseling,” wrote Marie L. Borum, MD, EdD, MPH, division of gastroenterology and liver diseases, George Washington University, Washington, D.C., and colleagues according to a news release. “It is recommended that individuals with IBD who are treated with immunosuppressants be counseled regarding preventative measures to reduce their risk of skin cancer.” With the aim of understanding the disparities between physician counseling practices regarding the risk of skin cancer, Dr. Borum and colleagues conducted a retrospective study where they collected and analyzed clinical data on 136 chronic IBD patients accompanied at an urban medical center for a period of one year. Of the patients analyzed, 27.9% (n = 38) were under immunomodulator therapy, and of these, 28 patients were on monotherapy and 10 patients were on combined immunomodulator and biologic therapy. Nearly 12% of the patient cohort was receiving biologic monotherapy (n = 17), and 81 patients were neither under immunomodulator nor biologic therapy. In total, the results revealed that 32% of the patients under treatment with immunomodulators received skin protection counseling. “IBD patients
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *